Intensive glycemic control may prevent diabetic foot ulcers

medwireNews: Early intensive glycemic control may reduce the long-term risk for foot ulcers in people with type 1 diabetes, suggest data from the Diabetes Control and Complications Trial (DCCT) and Epidemiology of Diabetes Interventions and Complications (EDIC) study … The DCCT included 1408 people with type 1 diabetes who completed an average of 6.5 years of intensive (target glycated hemoglobin [HbA1c] <6.05% [42.6 mmol/mol]) or conventional (no specific glycemic target) diabetes treatment and subsequently underwent 23 years of follow-up in the EDIC study … During this period, 195 participants developed at least one diabetic foot ulcer (48 people had multiple events) and 36 needed lower extremity amputation … read more

AmnioText from Regenative Labs

AmnioTextâ„¢ patches are produced from human amniotic membranes and can be placed on the wound closure sites after a medical procedure or directly onto an open wound. The allografts are minimally manipulated and undergo an extensive and comprehensive testing process. The patches are produced in our first-class, state-of-the-art lab in Pensacola, Florida, to ensure the highest quality tissue allografts available. Click here to request more information